ID KIF1B_RAT Reviewed; 1816 AA.
AC O88658; A0A8I5ZK86; Q65Z71; Q8R524;
DT 11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT 20-DEC-2005, sequence version 2.
DT 04-NOV-2026, entry version 199.
DE RecName: Full=Kinesin-like protein KIF1B {ECO:0000305|PubMed:12204119};
DE EC=5.6.1.3 {ECO:0000305|PubMed:15086790};
GN Name=Kif1b {ECO:0000312|RGD:621520};
OS Rattus norvegicus (Rat).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Rattus.
OX NCBI_TaxID=10116;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX PubMed=9808286; DOI=10.1016/s0171-9335(98)80099-x;
RA Faire K., Gruber D., Bulinski J.C.;
RT "Identification of kinesin-like molecules in myogenic cells.";
RL Eur. J. Cell Biol. 77:27-34(1998).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION (ISOFORM 1), INTERACTION
RP WITH CHP1, SUBCELLULAR LOCATION (ISOFORM 1), AND TISSUE SPECIFICITY.
RC TISSUE=Brain;
RX PubMed=12204119; DOI=10.1093/oxfordjournals.jbchem.a003246;
RA Nakamura N., Miyake Y., Matsushita M., Tanaka S., Inoue H., Kanazawa H.;
RT "KIF1Bbeta2, capable of interacting with CHP, is localized to synaptic
RT vesicles.";
RL J. Biochem. 132:483-491(2002).
RN [3]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION (ISOFORM 2), CATALYTIC
RP ACTIVITY, SUBCELLULAR LOCATION (ISOFORM 2), AND TISSUE SPECIFICITY (ISOFORM
RP 2).
RX PubMed=15086790; DOI=10.1111/j.1600-0854.2003.00165.x;
RA Matsushita M., Tanaka S., Nakamura N., Inoue H., Kanazawa H.;
RT "A novel kinesin-like protein, KIF1Bbeta3 is involved in the movement of
RT lysosomes to the cell periphery in non-neuronal cells.";
RL Traffic 5:140-151(2004).
RN [4]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORM 4).
RC STRAIN=Brown Norway;
RX PubMed=15057822; DOI=10.1038/nature02426;
RA Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA Mockrin S., Collins F.S.;
RT "Genome sequence of the Brown Norway rat yields insights into mammalian
RT evolution.";
RL Nature 428:493-521(2004).
RN [5]
RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1057; SER-1454; SER-1487 AND
RP SER-1613, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX PubMed=22673903; DOI=10.1038/ncomms1871;
RA Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA Olsen J.V.;
RT "Quantitative maps of protein phosphorylation sites across 14 different rat
RT organs and tissues.";
RL Nat. Commun. 3:876-876(2012).
CC -!- FUNCTION: Has a plus-end-directed microtubule motor activity and
CC functions as a motor for transport of vesicles and organelles along
CC microtubules. {ECO:0000269|PubMed:12204119,
CC ECO:0000269|PubMed:15086790}.
CC -!- FUNCTION: [Isoform 1]: Has a plus-end-directed microtubule motor
CC activity and functions as a motor for anterograde synaptic vesicle
CC transport along axonal microtubules from the cell body to the
CC presynapse in neuronal cells. {ECO:0000305|PubMed:12204119}.
CC -!- FUNCTION: [Isoform 2]: Has a plus-end-directed microtubule motor
CC activity and functions as a motor for the translocation of lysosomes
CC from perinuclear regions to the cell periphery.
CC {ECO:0000305|PubMed:15086790}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + H2O + a kinesin associated with a microtubule at
CC position (n) = ADP + phosphate a kinesin associated with a
CC microtubule at position (n+1, toward the plus end).; EC=5.6.1.3;
CC Evidence={ECO:0000305|PubMed:15086790};
CC -!- SUBUNIT: Monomer (By similarity). Interacts with KIFBP; positively
CC regulates KIF1B microtubule motor activity (By similarity). Interacts
CC (via C-terminus end of the kinesin-motor domain) with CHP1; the
CC interaction occurs in a calcium-dependent manner (PubMed:12204119).
CC Interacts with MADD (via death domain); links this isoform of KIF1B to
CC Rab3-carrying vesicles in anterograde synaptic vesicle transport (By
CC similarity). {ECO:0000250|UniProtKB:O60333,
CC ECO:0000250|UniProtKB:Q60575, ECO:0000269|PubMed:12204119}.
CC -!- INTERACTION:
CC O88658-1; P61023: Chp1; NbExp=4; IntAct=EBI-6143515, EBI-917838;
CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC {ECO:0000305|PubMed:12204119, ECO:0000305|PubMed:15086790}. Note=Has a
CC plus-end-directed microtubule motor activity and therefore associates
CC with microtubules. {ECO:0000305|PubMed:12204119,
CC ECO:0000305|PubMed:15086790}.
CC -!- SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasmic vesicle, secretory
CC vesicle, synaptic vesicle membrane {ECO:0000269|PubMed:12204119}.
CC Note=Associates with synaptic vesicles and mediates their anterograde
CC transport along axonal microtubules. {ECO:0000305|PubMed:12204119}.
CC -!- SUBCELLULAR LOCATION: [Isoform 2]: Lysosome
CC {ECO:0000305|PubMed:15086790}. Note=Associates with lysosome and
CC mediates their movement along microtubules.
CC {ECO:0000305|PubMed:15086790}.
CC -!- ALTERNATIVE PRODUCTS:
CC Event=Alternative splicing; Named isoforms=4;
CC Name=1; Synonyms=KIF1Bbeta2 {ECO:0000303|PubMed:15086790};
CC IsoId=O88658-1; Sequence=Displayed;
CC Name=2; Synonyms=KIF1Bbeta3 {ECO:0000303|PubMed:15086790};
CC IsoId=O88658-2; Sequence=VSP_016617, VSP_016619, VSP_016622;
CC Name=3; Synonyms=KIF1B;
CC IsoId=O88658-3; Sequence=VSP_016617, VSP_016618, VSP_016620,
CC VSP_016621;
CC Name=4;
CC IsoId=O88658-4; Sequence=VSP_016617, VSP_062357, VSP_062358;
CC -!- TISSUE SPECIFICITY: [Isoform 1]: Expressed in the brain with lower
CC expression in testis and liver (at protein level). Strongly expressed
CC in the brain and ovary, with lower expression in lung, kidney, uterus,
CC testis and liver. {ECO:0000269|PubMed:12204119}.
CC -!- TISSUE SPECIFICITY: [Isoform 2]: Isoform 2 is expressed in non-neuronal
CC tissues. {ECO:0000269|PubMed:15086790}.
CC -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC superfamily. Kinesin family. Unc-104 subfamily. {ECO:0000255|PROSITE-
CC ProRule:PRU00283}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF083331; AAC33292.1; -; mRNA.
DR EMBL; AB070355; BAB86917.1; -; mRNA.
DR EMBL; AB120429; BAD51401.1; -; mRNA.
DR EMBL; AABR07050461; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AABR07073193; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AC123476; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AC135710; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR RefSeq; NP_476548.1; NM_057200.2. [O88658-1]
DR RefSeq; XP_038965109.1; XM_039109181.2. [O88658-2]
DR RefSeq; XP_063143164.1; XM_063287094.1. [O88658-4]
DR AlphaFoldDB; O88658; -.
DR SMR; O88658; -.
DR CORUM; O88658; -.
DR FunCoup; O88658; 2077.
DR IntAct; O88658; 5.
DR STRING; 10116.ENSRNOP00000074322; -.
DR iPTMnet; O88658; -.
DR PhosphoSitePlus; O88658; -.
DR jPOST; O88658; -.
DR PaxDb; 10116-ENSRNOP00000074322; -.
DR Ensembl; ENSRNOT00000086226.3; ENSRNOP00000077156.1; ENSRNOG00000057626.3. [O88658-4]
DR Ensembl; ENSRNOT00055024087; ENSRNOP00055019651; ENSRNOG00055013961. [O88658-4]
DR Ensembl; ENSRNOT00060048552; ENSRNOP00060040467; ENSRNOG00060027832. [O88658-4]
DR Ensembl; ENSRNOT00065017997; ENSRNOP00065013721; ENSRNOG00065011092. [O88658-4]
DR GeneID; 117548; -.
DR KEGG; rno:117548; -.
DR UCSC; RGD:621520; rat. [O88658-1]
DR AGR; RGD:621520; -.
DR CTD; 23095; -.
DR RGD; 621520; Kif1b.
DR eggNOG; KOG0245; Eukaryota.
DR GeneTree; ENSGT00940000157445; -.
DR InParanoid; O88658; -.
DR PhylomeDB; O88658; -.
DR Reactome; R-RNO-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR Reactome; R-RNO-983189; Kinesins.
DR PRO; PR:O88658; -.
DR Proteomes; UP000002494; Chromosome 5.
DR Bgee; ENSRNOG00000057626; Expressed in frontal cortex and 19 other cell types or tissues.
DR ExpressionAtlas; O88658; baseline and differential.
DR GO; GO:0030424; C:axon; IBA:GO_Central.
DR GO; GO:1904115; C:axon cytoplasm; IEA:GOC.
DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR GO; GO:0005871; C:kinesin complex; IBA:GO_Central.
DR GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR GO; GO:0005874; C:microtubule; IBA:GO_Central.
DR GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR GO; GO:0098794; C:postsynapse; ISO:RGD.
DR GO; GO:0098793; C:presynapse; ISO:RGD.
DR GO; GO:0030672; C:synaptic vesicle membrane; ISS:UniProtKB.
DR GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR GO; GO:0016887; F:ATP hydrolysis activity; IDA:RGD.
DR GO; GO:0019900; F:kinase binding; IPI:RGD.
DR GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR GO; GO:0003777; F:microtubule motor activity; IDA:RGD.
DR GO; GO:0008574; F:plus-end-directed microtubule motor activity; ISS:UniProtKB.
DR GO; GO:0097110; F:scaffold protein binding; IPI:RGD.
DR GO; GO:1990048; P:anterograde neuronal dense core vesicle transport; IGI:ARUK-UCL.
DR GO; GO:0048490; P:anterograde synaptic vesicle transport; ISS:UniProtKB.
DR GO; GO:1902742; P:apoptotic process involved in development; ISO:RGD.
DR GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEP:RGD.
DR GO; GO:0032418; P:lysosome localization; IMP:RGD.
DR GO; GO:0047497; P:mitochondrion transport along microtubule; ISS:UniProtKB.
DR GO; GO:0007274; P:neuromuscular synaptic transmission; ISS:UniProtKB.
DR GO; GO:0007270; P:neuron-neuron synaptic transmission; ISS:UniProtKB.
DR GO; GO:0072384; P:organelle transport along microtubule; IMP:UniProtKB.
DR GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR GO; GO:1990778; P:protein localization to cell periphery; IMP:RGD.
DR GO; GO:1904647; P:response to rotenone; IEP:RGD.
DR GO; GO:1990049; P:retrograde neuronal dense core vesicle transport; IGI:ARUK-UCL.
DR GO; GO:0010970; P:transport along microtubule; IDA:RGD.
DR GO; GO:0016192; P:vesicle-mediated transport; IBA:GO_Central.
DR CDD; cd22727; FHA_KIF1B; 1.
DR CDD; cd01365; KISc_KIF1A_KIF1B; 1.
DR CDD; cd01233; PH_KIFIA_KIFIB; 1.
DR FunFam; 2.30.29.30:FF:000023; Kinesin family member 1B; 1.
DR FunFam; 2.60.200.20:FF:000001; Kinesin family member 1B; 1.
DR FunFam; 3.40.850.10:FF:000004; Kinesin-like protein isoform 2; 1.
DR Gene3D; 2.60.200.20; -; 1.
DR Gene3D; 6.10.250.2520; -; 1.
DR Gene3D; 3.40.850.10; Kinesin motor domain; 1.
DR Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR InterPro; IPR000253; FHA_dom.
DR InterPro; IPR022164; Kinesin-like.
DR InterPro; IPR022140; Kinesin-like_KIF1-typ.
DR InterPro; IPR032405; Kinesin_assoc.
DR InterPro; IPR019821; Kinesin_motor_CS.
DR InterPro; IPR001752; Kinesin_motor_dom.
DR InterPro; IPR036961; Kinesin_motor_dom_sf.
DR InterPro; IPR027417; P-loop_NTPase.
DR InterPro; IPR011993; PH-like_dom_sf.
DR InterPro; IPR001849; PH_domain.
DR InterPro; IPR049780; PH_KIFIA_KIFIB.
DR InterPro; IPR008984; SMAD_FHA_dom_sf.
DR PANTHER; PTHR47117:SF4; KINESIN-LIKE PROTEIN KIF1B ISOFORM X1; 1.
DR PANTHER; PTHR47117; STAR-RELATED LIPID TRANSFER PROTEIN 9; 1.
DR Pfam; PF12473; DUF3694; 1.
DR Pfam; PF00498; FHA; 1.
DR Pfam; PF12423; KIF1B; 1.
DR Pfam; PF00225; Kinesin; 1.
DR Pfam; PF16183; Kinesin_assoc; 1.
DR Pfam; PF00169; PH; 1.
DR PRINTS; PR00380; KINESINHEAVY.
DR SMART; SM00240; FHA; 1.
DR SMART; SM00129; KISc; 1.
DR SMART; SM00233; PH; 1.
DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR SUPFAM; SSF50729; PH domain-like; 1.
DR SUPFAM; SSF49879; SMAD/FHA domain; 1.
DR PROSITE; PS50006; FHA_DOMAIN; 1.
DR PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR PROSITE; PS50067; KINESIN_MOTOR_2; 1.
DR PROSITE; PS50003; PH_DOMAIN; 1.
PE 1: Evidence at protein level;
KW Acetylation; Alternative splicing; ATP-binding; Coiled coil; Cytoplasm;
KW Cytoplasmic vesicle; Cytoskeleton; Isomerase; Lysosome; Membrane;
KW Microtubule; Motor protein; Nucleotide-binding; Phosphoprotein;
KW Reference proteome; Synapse.
FT INIT_MET 1
FT /note="Removed"
FT /evidence="ECO:0000250|UniProtKB:O60333"
FT CHAIN 2..1816
FT /note="Kinesin-like protein KIF1B"
FT /id="PRO_0000125409"
FT DOMAIN 5..354
FT /note="Kinesin motor"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT DOMAIN 556..612
FT /note="FHA"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00086"
FT DOMAIN 1701..1799
FT /note="PH"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT REGION 270..350
FT /note="Interaction with KIFBP"
FT /evidence="ECO:0000250|UniProtKB:O60333"
FT REGION 431..450
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 1550..1570
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 1620..1659
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COILED 470..512
FT /evidence="ECO:0000255"
FT COILED 672..731
FT /evidence="ECO:0000255"
FT COMPBIAS 432..450
FT /note="Low complexity"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 1620..1637
FT /note="Low complexity"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 1640..1659
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT BINDING 97..104
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT MOD_RES 2
FT /note="N-acetylserine"
FT /evidence="ECO:0000250|UniProtKB:O60333"
FT MOD_RES 647
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250|UniProtKB:Q60575"
FT MOD_RES 652
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250|UniProtKB:Q60575"
FT MOD_RES 1054
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O60333"
FT MOD_RES 1057
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:22673903"
FT MOD_RES 1416
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O60333"
FT MOD_RES 1454
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:22673903"
FT MOD_RES 1487
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:22673903"
FT MOD_RES 1573
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O60333"
FT MOD_RES 1603
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O60333"
FT MOD_RES 1610
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O60333"
FT MOD_RES 1613
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:22673903"
FT VAR_SEQ 289..294
FT /note="Missing (in isoform 2, isoform 3 and isoform 4)"
FT /evidence="ECO:0000303|PubMed:15086790,
FT ECO:0000303|PubMed:9808286"
FT /id="VSP_016617"
FT VAR_SEQ 342
FT /note="L -> LST (in isoform 3)"
FT /evidence="ECO:0000303|PubMed:9808286"
FT /id="VSP_016618"
FT VAR_SEQ 394..434
FT /note="IDPLMDDYSGSGGKYLKDFQNNKHRYLLASENQRPGNFSTA -> T (in
FT isoform 2)"
FT /evidence="ECO:0000303|PubMed:15086790"
FT /id="VSP_016619"
FT VAR_SEQ 394..408
FT /note="IDPLMDDYSGSGGKY -> N (in isoform 3)"
FT /evidence="ECO:0000303|PubMed:9808286"
FT /id="VSP_016620"
FT VAR_SEQ 707..1816
FT /note="Missing (in isoform 3)"
FT /evidence="ECO:0000303|PubMed:9808286"
FT /id="VSP_016621"
FT VAR_SEQ 707..1196
FT /note="YESKLQALQKQVETRSLAAETTEEEEEEEEVPWTQHEFELAQWAFRKWKSHQ
FT FTSLRDLLWGNAVYLKEANAISVELKKKVQFQFVLLTDTLYSPVPPELLPTEMGKTHED
FT RPFPRTVVAVEVQDLKNGATHYWSLDKLKQRLDLMREMYDRAGEVGSNAQDDSETTMTG
FT SDPFYDRFHWFKLVGSSPIFHGCVNERLADRTPSPTFSTADSDITELADEQQDAMEDFD
FT DEAFVDDTGSDAGTEEGSELFSDGHDPFYDRSPWFILVGRAFVYLSNLLYPVPLIHRVA
FT IVSEKGEVRGFLRVAVQAIAADEEAPDYGSGIRQSGTAKISFDNEYFNQSDFPSAAMTR
FT SGLSLEELRIVEGQGQSSEVISPPEEVNRMNDLDLKSGTLLDGKMVMEGFSEEIGNHLK
FT LGSAFTFRVTVLQASGILPEYADIFCQFNFLHRHDEAFSTEPLKNNGRGSPLGFYHVQN
FT IAVEVTESFVDYIKTKPIVFEVFGH -> ADSDSGDDSDKRSCEESWKLITSLREKLPP
FT SKLQTIVKKCGLPSSGKKREPIKMYQIPQRRRLSKDSKWVTISDLKIQAVKEICYEVAL
FT NDFRHSRQEIEALAIVKMKELCAMYGKKDPNERDSWRAVARDVWDTVGVGDEKIEDMMV
FT TGKAGTDVDDLKVHIDKLEDILQEVKKQNNMKDEEIKVLRNKMLKMEKVLPLIGSQEQK
FT SQGNQKTEEPLVASANSIPDTGIRKGDSRELAKEERVSQLMNGDPAFRRGRLRWMRQEQ
FT IRFKNLQQQEITKQLRRQNVPHRFIPPENRKPRFPFKSNAKHRNSWSPGTHIIITEDEV
FT IELRVPKDEEGRRGNKEEKVGRAASEDPQSACGSQGTRSQGHIQVSKQHIISQQAPPPL
FT RWRSNSLNNGQPKNMRCQAAASSESLNSHSSHPNADVQTFQAKRHIHQHRQSYCNYNTG
FT DQVEGSTANCCQKQTDKPSHCSQFETPPRMRRQFSAPNLKAGRETTV (in isoform
FT 4)"
FT /id="VSP_062357"
FT VAR_SEQ 889..971
FT /note="Missing (in isoform 2)"
FT /evidence="ECO:0000303|PubMed:15086790"
FT /id="VSP_016622"
FT VAR_SEQ 1197..1816
FT /note="Missing (in isoform 4)"
FT /id="VSP_062358"
FT CONFLICT 121..122
FT /note="QL -> TC (in Ref. 1; AAC33292)"
FT /evidence="ECO:0000305"
FT CONFLICT 143..144
FT /note="EV -> S (in Ref. 1; AAC33292)"
FT /evidence="ECO:0000305"
FT CONFLICT 242
FT /note="S -> T (in Ref. 1; AAC33292)"
FT /evidence="ECO:0000305"
FT CONFLICT 269
FT /note="A -> R (in Ref. 1; AAC33292)"
FT /evidence="ECO:0000305"
FT CONFLICT 533..534
FT /note="HL -> QV (in Ref. 1; AAC33292)"
FT /evidence="ECO:0000305"
FT CONFLICT 557..558
FT /note="RV -> KGF (in Ref. 1; AAC33292)"
FT /evidence="ECO:0000305"
FT CONFLICT 575
FT /note="H -> HT (in Ref. 1; AAC33292)"
FT /evidence="ECO:0000305"
FT CONFLICT 622..627
FT /note="NRIIMG -> TVSSWV (in Ref. 1; AAC33292)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 1816 AA; 204170 MW; 7A6EBD08EBAC2BF9 CRC64;
MSGASVKVAV RVRPFNSRET SKESKCIIQM QGNSTSIINP KNPKEAPKSF SFDYSYWSHT
SPEDPCFASQ SRVYNDIGKE MLLHAFEGYN VCIFAYGQTG AGKSYTMMGK QEESQAGIIP
QLCEELFEKI NDNCNEDMSY SVEVSYMEIY CERVRDLLNP KNKGNLRVRE HPLLGPYVED
LSKLAVTSYT DIADLMDAGN KARTVAATNM NETSSRSHAV FTIVFTQKKQ DPETNLSTEK
VSKISLVDLA GSERADSTGA KGTRLKEGAN INKSLTTLGK VISALAEVDN CTSKSKKKKK
TDFIPYRDSV LTWLLRENLG GNSRTAMVAA LSPADINYDE TLSTLRYADR AKQIKCNAVI
NEDPNAKLVR ELKEEVTRLK DLLRAQGLGD IIDIDPLMDD YSGSGGKYLK DFQNNKHRYL
LASENQRPGN FSTASMGSLT SSPSSCSLNS QAGLTSVTSI QERIMSTPGG EEAIERLKES
EKIIAELNET WEEKLRKTEA IRMEREALLA EMGVAIREDG GTLGVFSPKK TPHLVNLNED
PLMSECLLYY IKDGITRVGQ ADAERRQDIV LSGAHIKEEH CIFRSERNNT GEVIVTLEPC
ERSETYVNGK RVAHPVQLRS GNRIIMGKNH VFRFNHPEQA RAEREKTPSA ETPSEPVDWT
FAQRELLEKQ GIDMKQEMEK RLQEMEILYK REKEEADLLL EQQRLDYESK LQALQKQVET
RSLAAETTEE EEEEEEVPWT QHEFELAQWA FRKWKSHQFT SLRDLLWGNA VYLKEANAIS
VELKKKVQFQ FVLLTDTLYS PVPPELLPTE MGKTHEDRPF PRTVVAVEVQ DLKNGATHYW
SLDKLKQRLD LMREMYDRAG EVGSNAQDDS ETTMTGSDPF YDRFHWFKLV GSSPIFHGCV
NERLADRTPS PTFSTADSDI TELADEQQDA MEDFDDEAFV DDTGSDAGTE EGSELFSDGH
DPFYDRSPWF ILVGRAFVYL SNLLYPVPLI HRVAIVSEKG EVRGFLRVAV QAIAADEEAP
DYGSGIRQSG TAKISFDNEY FNQSDFPSAA MTRSGLSLEE LRIVEGQGQS SEVISPPEEV
NRMNDLDLKS GTLLDGKMVM EGFSEEIGNH LKLGSAFTFR VTVLQASGIL PEYADIFCQF
NFLHRHDEAF STEPLKNNGR GSPLGFYHVQ NIAVEVTESF VDYIKTKPIV FEVFGHYQQH
PLHLQGQELN SPPQPSRRFF PPPMPLSRPV PATKLNTMNK TSLGQSMSKY DLLVWFEISE
LEPTGEYIPA VVDHTAGLPC QGTFLLHQGI QRRITVTIIH EKGSELHWKD VRELVVGRIR
NKPEVDEAAV DAILSLNIIS AKSLKSSHSS SRTFYRFEAV WDSSLHNSLL LNRVTPYGEK
IYMTLSAYLE LDHCIQPAVI TKDVCMVFYS RDAKISPPRS LRNLFGSGYS KSPDSNRVTG
IYELSLCKMA DTGSPGMQRR RRKVLDTSVA YVRGEENLAG WRPRGDSLIL EHQWELEKLE
LLHEVEKTRH FLLLRERLGD SIPKSMSDSL SPSLSSGTLS TSTSISSQIS TTTFESAITP
SESSGYDSAD IESLVDREKE LATKCLQLLT HTFNREFSQV HGSISDCKLS DISPIGRDPS
VSSFSSSTLT PSSTCPSLVD SRSSSMDQKT PEANSRASSP CQEFEQFQII PTVETPYLAR
AGKNEFLNLV PDIEEVRAGS VVSKKGYLHF KEPLSSNWAK HFVVVRRPYV FIYNSDKDPV
ERGIINLSTA QVEYSEDQQA MLKTPNTFAV CTKHRGVLLQ ALNDKDMNDW LYAFNPLLAG
TIRSKLSRRC PSQPKY
//